NLH TSXV · Healthcare · FY 2025-12-31

Nova Leap Health Corp.

Back to TSXV
0.00.10.20.30.3ABVfair 0.02buy ≤ 0.00EPVfair 0.11buy ≤ 0.02EBVnot valid for this companyDBVnot valid for this companyprice 0.31 USD
0.00.10.20.40.5ABVfair 0.02buy ≤ 0.01EPVfair 0.15buy ≤ 0.03EBVnot valid for this companyDBVnot valid for this companyprice 0.43 CAD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USDCAD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●●○ Medium · 2/4
Price
0.3090.435 USDCAD *
Market cap
27.0M38.0M USDCAD *
P / B
1.42
P / E
—
EPS
-0.002-0.003
DPS / yield
— (0.0%)
NAV / share
0.0160.023
Graham number
—
Z'' score
4.38
Piotroski F
6 / 9
Beneish M
-2.81
ROIC vs WACC
1.0% vs 14.2%

* Listed in CAD — the pipeline states price and all valuations in the filing currency USD (fx 0.71 USD/CAD).

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.